Compare COCO & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COCO | NNNN |
|---|---|---|
| Founded | 2004 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 1.0B |
| IPO Year | 2021 | 2025 |
| Metric | COCO | NNNN |
|---|---|---|
| Price | $54.60 | $37.00 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $55.13 | N/A |
| AVG Volume (30 Days) | ★ 923.0K | 25.7K |
| Earning Date | 10-29-2025 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.16 | N/A |
| EPS | ★ 1.15 | 0.06 |
| Revenue | ★ $609,286,000.00 | $8,185,146.00 |
| Revenue This Year | $18.22 | N/A |
| Revenue Next Year | $13.69 | N/A |
| P/E Ratio | ★ $47.36 | $684.40 |
| Revenue Growth | ★ 23.12 | 21.95 |
| 52 Week Low | $25.79 | $5.18 |
| 52 Week High | $55.09 | $55.65 |
| Indicator | COCO | NNNN |
|---|---|---|
| Relative Strength Index (RSI) | 74.25 | 67.42 |
| Support Level | $53.63 | $21.13 |
| Resistance Level | $55.09 | $29.38 |
| Average True Range (ATR) | 2.08 | 4.90 |
| MACD | 0.47 | 2.01 |
| Stochastic Oscillator | 93.61 | 75.29 |
The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.